CCTG 593: Testing and Linkage to Care
1 other identifier
interventional
600
1 country
3
Brief Summary
This is a CCTG sponsored project to determine if those recently screened for HIV would accept assistance to be linked into appropriate health services. After receiving their HIV results, high-risk individuals who test negative will have an option to be linked into a study that offers them Pre-exposure Prophylaxis (PrEP), and individuals who test positive will have an option to be linked into care. If they accept, tested individuals will be in contact with an ALERT specialist that will help facilitate their linkage. The study's primary analysis will analyze how many HIV screened individuals accept the ALERT specialist assistance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 26, 2013
CompletedFirst Submitted
Initial submission to the registry
September 9, 2013
CompletedFirst Posted
Study publicly available on registry
September 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2021
CompletedMay 12, 2021
May 1, 2021
4.5 years
September 9, 2013
May 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of subjects linked to Care or PrEP
The primary outcome will measure the proportion of subjects linked a) to HIV care within 60 days of testing HIV-positive or b) to PrEP within 90 days of testing HIV-negative
Up to 60 days for positives and up to 90 days for negatives from date of HIV screening test
Secondary Outcomes (1)
Acceptance of the linkage program
60 days from date of HIV screening test
Study Arms (1)
Linkage to PrEP or Care
EXPERIMENTALSubjects screened for HIV at any CCTG consortium site will be offered Linkage to PrEP or Care, depending on HIV status. After results are received, HIV testers will obtain verbal consent from the subject to connect with the ALERT Specialist, or otherwise offer the subject the ALERT Specialist contact information. When contacted, the ALERT Specialist will coordinate with the subject the scheduling of the PrEP or Care visit, and remain in contact to ensure linkage.
Interventions
Ensuring subjects complete linkage to PrEP or Care through coordinated scheduling and intensive reminders by ALERT Specialist.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Has had an HIV test result form the CCTG Consortium testing site as either positive or negative
- Ability to provide informed consent
- English or Spanish Speaking
You may not qualify if:
- Severe active substance abuse or mental illness that the investigator feels will interfere with the ability to provide informed consent
- Acute medical illness that requires transfer to a non CCTG hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- University of California, Los Angelescollaborator
- University of Southern Californiacollaborator
- City of Long Beach Department of Health and Human Servicescollaborator
- California HIV/AIDS Research Programcollaborator
Study Sites (3)
City of Long Beach Department of Health and Human Services
Long Beach, California, 90815, United States
University of Southern California
Los Angeles, California, 90033, United States
University of California, San Diego
San Diego, California, 92103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kathleen Jacobson, MD
University of Southern California
- STUDY CHAIR
Michael Menchine, MD, MPH
University of Southern California
- PRINCIPAL INVESTIGATOR
Jill Blumenthal, MD
UC San Diego AntiViral Research Center (AVRC)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 9, 2013
First Posted
September 13, 2013
Study Start
July 26, 2013
Primary Completion
January 22, 2018
Study Completion
February 9, 2021
Last Updated
May 12, 2021
Record last verified: 2021-05